A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

NCT03933982 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Brain Metastases

Interventions

DRUG: Pyrotinib Plus Vinorelbine

Sponsor

Chinese Academy of Medical Sciences